James Miyazaki
Family · Caldwell, IDNPI 1740596873
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 279 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 19.5% — the pattern of someone who eats at a lot of different presentations. Among family clinicians in ID with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 279 payments — averaging $22.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Novo Nordisk$799
- Lilly USA, LLC$734
- Boehringer Ingelheim$468
- AstraZeneca$403
- Merck$303
- plus $2K from 28 others
What the payments were for
- Food & beverage$6,144100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 68 | $1,198 |
| Novo Nordisk | 33 | $799 |
| Lilly USA, LLC | 31 | $734 |
| Boehringer Ingelheim | 20 | $468 |
| AstraZeneca | 9 | $403 |
| Merck | 13 | $303 |
| Abbott | 16 | $303 |
| Corcept Therapeutics | 9 | $219 |
| Sanofi Pasteur Inc. | 8 | $181 |
| Pfizer | 8 | $170 |
| Xeris Pharmaceuticals, Inc. | 8 | $163 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 5 | $143 |
| Bayer | 6 | $125 |
| Zealand Pharma US, Inc. | 6 | $113 |
| Otsuka America Pharmaceutical, Inc. | 4 | $94 |
| Exact Sciences | 3 | $86 |
| GSK | 3 | $77 |
| Phathom Pharmaceuticals, Inc. | 3 | $74 |
| Novartis | 3 | $68 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $61 |
| Medtronic | 4 | $58 |
| Amgen(2 entities) | 3 | $57 |
| Phadia US Inc. | 2 | $31 |
| Neurocrine Biosciences, Inc. | 1 | $29 |
| Radius Health, Inc. | 1 | $24 |
| Lundbeck LLC | 1 | $22 |
| Idorsia Pharmaceuticals US Inc | 1 | $21 |
| Sanofi-aventis U.S. LLC | 1 | $21 |
| Amarin Pharma, Inc. | 1 | $20 |
| Alk-abello, Inc | 1 | $20 |
| Sunovion Pharmaceuticals Inc. | 1 | $19 |
| Hikma Pharmaceuticals USA | 1 | $14 |
| Cequr Corporation | 1 | $13 |
| Gilead | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,144 in reported general payments places this provider in the 95th percentile of 809 family providers in Idaho.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 25 | $25,878 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 80 | $2,255 |
| Losartan Potassium | 35 | $594 |
| Atorvastatin Calcium | 52 | $553 |
| Tamsulosin Hcl | 19 | $443 |
| Amlodipine Besylate | 53 | $361 |
| Metformin Hcl | 51 | $338 |
| Cyclobenzaprine Hcl | 20 | $323 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 42 | $301 |
| Alendronate Sodium | 29 | $293 |
| Ibuprofen | 14 | $194 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 12 | $190 |
| Mupirocin | 40 | $184 |
| Hydroxyzine Hcl | 17 | $175 |
| Lisinopril | 27 | $163 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $799 | $25,87825 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 809 family providers in Idaho.
Other family in Caldwell
- Bobbi BullockNampa$609K
- Michael ParkerMeridian$69K
- Jessica BraksiekBoise$41K
- Travis BlaserBoise$33K
- Alysha SchlackNampa$23K
- Jennifer WatsonCoeur D Alene$21K
- Amber MasseIdaho Falls$17K
- Brian KittelsonMeridian$16K
- Devon MoserBoise$11K
- Jessicka PricePocatello$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.